世界の抗ウイルス経口液市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antiviral Oral Liquid Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3844
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、128ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、抗ウイルス経口液の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シロップ、経口懸濁液、経口液剤、経口滴剤、経口乳濁液、混合物）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・抗ウイルス経口液の市場動向
・企業の競争状況、市場シェア
・抗ウイルス経口液の種類別市場規模と予測2016-2027（シロップ、経口懸濁液、経口液剤、経口滴剤、経口乳濁液、混合物）
・抗ウイルス経口液の用途別市場規模と予測2016-2027（大人用、子供用）
・抗ウイルス経口液の北米市場規模2016-2027（アメリカ、カナダ）
・抗ウイルス経口液の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗ウイルス経口液のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗ウイルス経口液の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗ウイルス経口液の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Roche、Novartis、Merck、GlaxoSmithKline、Johnson & Johnson、AbbVie、Sanofi、Bristol-Myers Squibb、AstraZeneca、Eli Lilly、Novo Nordisk、Amgen、Gilead Sciences、CSL、Takeda Pharmaceuticals、Bayer、Celgene、Merck KGaA、Allergan）
・結論

Antiviral Oral liquids are homogeneous liquid preparations, usually contains a solution, an emulsion or a suspension of one or more active ingredients in a suitable liquid base.

Market Analysis and Insights: Global Antiviral Oral Liquid Market
The global Antiviral Oral Liquid market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antiviral Oral Liquid market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antiviral Oral Liquid market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antiviral Oral Liquid market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antiviral Oral Liquid market.

Global Antiviral Oral Liquid Scope and Market Size
Antiviral Oral Liquid market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiviral Oral Liquid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Syrup
Oral suspension
Oral solution
Oral drop
Oral emulsion
Mixture

Segment by Application
Adults
Children

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Roche
Novartis
Merck
GlaxoSmithKline
Johnson & Johnson
AbbVie
Sanofi
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Novo Nordisk
Amgen
Gilead Sciences
CSL
Takeda Pharmaceuticals
Bayer
Celgene
Merck KGaA
Allergan

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Oral Liquid Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Syrup
1.2.3 Oral suspension
1.2.4 Oral solution
1.2.5 Oral drop
1.2.6 Oral emulsion
1.2.7 Mixture
1.3 Market by Application
1.3.1 Global Antiviral Oral Liquid Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antiviral Oral Liquid Market Perspective (2016-2027)
2.2 Antiviral Oral Liquid Growth Trends by Regions
2.2.1 Antiviral Oral Liquid Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antiviral Oral Liquid Historic Market Share by Regions (2016-2021)
2.2.3 Antiviral Oral Liquid Forecasted Market Size by Regions (2022-2027)
2.3 Antiviral Oral Liquid Industry Dynamic
2.3.1 Antiviral Oral Liquid Market Trends
2.3.2 Antiviral Oral Liquid Market Drivers
2.3.3 Antiviral Oral Liquid Market Challenges
2.3.4 Antiviral Oral Liquid Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antiviral Oral Liquid Players by Revenue
3.1.1 Global Top Antiviral Oral Liquid Players by Revenue (2016-2021)
3.1.2 Global Antiviral Oral Liquid Revenue Market Share by Players (2016-2021)
3.2 Global Antiviral Oral Liquid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiviral Oral Liquid Revenue
3.4 Global Antiviral Oral Liquid Market Concentration Ratio
3.4.1 Global Antiviral Oral Liquid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Oral Liquid Revenue in 2020
3.5 Antiviral Oral Liquid Key Players Head office and Area Served
3.6 Key Players Antiviral Oral Liquid Product Solution and Service
3.7 Date of Enter into Antiviral Oral Liquid Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antiviral Oral Liquid Breakdown Data by Type
4.1 Global Antiviral Oral Liquid Historic Market Size by Type (2016-2021)
4.2 Global Antiviral Oral Liquid Forecasted Market Size by Type (2022-2027)

5 Antiviral Oral Liquid Breakdown Data by Application
5.1 Global Antiviral Oral Liquid Historic Market Size by Application (2016-2021)
5.2 Global Antiviral Oral Liquid Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antiviral Oral Liquid Market Size (2016-2027)
6.2 North America Antiviral Oral Liquid Market Size by Type
6.2.1 North America Antiviral Oral Liquid Market Size by Type (2016-2021)
6.2.2 North America Antiviral Oral Liquid Market Size by Type (2022-2027)
6.2.3 North America Antiviral Oral Liquid Market Size by Type (2016-2027)
6.3 North America Antiviral Oral Liquid Market Size by Application
6.3.1 North America Antiviral Oral Liquid Market Size by Application (2016-2021)
6.3.2 North America Antiviral Oral Liquid Market Size by Application (2022-2027)
6.3.3 North America Antiviral Oral Liquid Market Size by Application (2016-2027)
6.4 North America Antiviral Oral Liquid Market Size by Country
6.4.1 North America Antiviral Oral Liquid Market Size by Country (2016-2021)
6.4.2 North America Antiviral Oral Liquid Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antiviral Oral Liquid Market Size (2016-2027)
7.2 Europe Antiviral Oral Liquid Market Size by Type
7.2.1 Europe Antiviral Oral Liquid Market Size by Type (2016-2021)
7.2.2 Europe Antiviral Oral Liquid Market Size by Type (2022-2027)
7.2.3 Europe Antiviral Oral Liquid Market Size by Type (2016-2027)
7.3 Europe Antiviral Oral Liquid Market Size by Application
7.3.1 Europe Antiviral Oral Liquid Market Size by Application (2016-2021)
7.3.2 Europe Antiviral Oral Liquid Market Size by Application (2022-2027)
7.3.3 Europe Antiviral Oral Liquid Market Size by Application (2016-2027)
7.4 Europe Antiviral Oral Liquid Market Size by Country
7.4.1 Europe Antiviral Oral Liquid Market Size by Country (2016-2021)
7.4.2 Europe Antiviral Oral Liquid Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antiviral Oral Liquid Market Size (2016-2027)
8.2 Asia-Pacific Antiviral Oral Liquid Market Size by Type
8.2.1 Asia-Pacific Antiviral Oral Liquid Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antiviral Oral Liquid Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antiviral Oral Liquid Market Size by Type (2016-2027)
8.3 Asia-Pacific Antiviral Oral Liquid Market Size by Application
8.3.1 Asia-Pacific Antiviral Oral Liquid Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antiviral Oral Liquid Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antiviral Oral Liquid Market Size by Application (2016-2027)
8.4 Asia-Pacific Antiviral Oral Liquid Market Size by Region
8.4.1 Asia-Pacific Antiviral Oral Liquid Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antiviral Oral Liquid Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antiviral Oral Liquid Market Size (2016-2027)
9.2 Latin America Antiviral Oral Liquid Market Size by Type
9.2.1 Latin America Antiviral Oral Liquid Market Size by Type (2016-2021)
9.2.2 Latin America Antiviral Oral Liquid Market Size by Type (2022-2027)
9.2.3 Latin America Antiviral Oral Liquid Market Size by Type (2016-2027)
9.3 Latin America Antiviral Oral Liquid Market Size by Application
9.3.1 Latin America Antiviral Oral Liquid Market Size by Application (2016-2021)
9.3.2 Latin America Antiviral Oral Liquid Market Size by Application (2022-2027)
9.3.3 Latin America Antiviral Oral Liquid Market Size by Application (2016-2027)
9.4 Latin America Antiviral Oral Liquid Market Size by Country
9.4.1 Latin America Antiviral Oral Liquid Market Size by Country (2016-2021)
9.4.2 Latin America Antiviral Oral Liquid Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antiviral Oral Liquid Market Size (2016-2027)
10.2 Middle East & Africa Antiviral Oral Liquid Market Size by Type
10.2.1 Middle East & Africa Antiviral Oral Liquid Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antiviral Oral Liquid Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antiviral Oral Liquid Market Size by Type (2016-2027)
10.3 Middle East & Africa Antiviral Oral Liquid Market Size by Application
10.3.1 Middle East & Africa Antiviral Oral Liquid Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antiviral Oral Liquid Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antiviral Oral Liquid Market Size by Application (2016-2027)
10.4 Middle East & Africa Antiviral Oral Liquid Market Size by Country
10.4.1 Middle East & Africa Antiviral Oral Liquid Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antiviral Oral Liquid Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antiviral Oral Liquid Introduction
11.1.4 Pfizer Revenue in Antiviral Oral Liquid Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Antiviral Oral Liquid Introduction
11.2.4 Roche Revenue in Antiviral Oral Liquid Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Antiviral Oral Liquid Introduction
11.3.4 Novartis Revenue in Antiviral Oral Liquid Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Antiviral Oral Liquid Introduction
11.4.4 Merck Revenue in Antiviral Oral Liquid Business (2016-2021)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Antiviral Oral Liquid Introduction
11.5.4 GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antiviral Oral Liquid Introduction
11.6.4 Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Antiviral Oral Liquid Introduction
11.7.4 AbbVie Revenue in Antiviral Oral Liquid Business (2016-2021)
11.7.5 AbbVie Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Antiviral Oral Liquid Introduction
11.8.4 Sanofi Revenue in Antiviral Oral Liquid Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Introduction
11.9.4 Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Antiviral Oral Liquid Introduction
11.10.4 AstraZeneca Revenue in Antiviral Oral Liquid Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Antiviral Oral Liquid Introduction
11.11.4 Eli Lilly Revenue in Antiviral Oral Liquid Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Details
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Antiviral Oral Liquid Introduction
11.12.4 Novo Nordisk Revenue in Antiviral Oral Liquid Business (2016-2021)
11.12.5 Novo Nordisk Recent Development
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Antiviral Oral Liquid Introduction
11.13.4 Amgen Revenue in Antiviral Oral Liquid Business (2016-2021)
11.13.5 Amgen Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Antiviral Oral Liquid Introduction
11.14.4 Gilead Sciences Revenue in Antiviral Oral Liquid Business (2016-2021)
11.14.5 Gilead Sciences Recent Development
11.15 CSL
11.15.1 CSL Company Details
11.15.2 CSL Business Overview
11.15.3 CSL Antiviral Oral Liquid Introduction
11.15.4 CSL Revenue in Antiviral Oral Liquid Business (2016-2021)
11.15.5 CSL Recent Development
11.16 Takeda Pharmaceuticals
11.16.1 Takeda Pharmaceuticals Company Details
11.16.2 Takeda Pharmaceuticals Business Overview
11.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Introduction
11.16.4 Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2016-2021)
11.16.5 Takeda Pharmaceuticals Recent Development
11.17 Bayer
11.17.1 Bayer Company Details
11.17.2 Bayer Business Overview
11.17.3 Bayer Antiviral Oral Liquid Introduction
11.17.4 Bayer Revenue in Antiviral Oral Liquid Business (2016-2021)
11.17.5 Bayer Recent Development
11.18 Celgene
11.18.1 Celgene Company Details
11.18.2 Celgene Business Overview
11.18.3 Celgene Antiviral Oral Liquid Introduction
11.18.4 Celgene Revenue in Antiviral Oral Liquid Business (2016-2021)
11.18.5 Celgene Recent Development
11.18 Merck KGaA
.1 Merck KGaA Company Details
.2 Merck KGaA Business Overview
.3 Merck KGaA Antiviral Oral Liquid Introduction
.4 Merck KGaA Revenue in Antiviral Oral Liquid Business (2016-2021)
.5 Merck KGaA Recent Development
11.20 Allergan
11.20.1 Allergan Company Details
11.20.2 Allergan Business Overview
11.20.3 Allergan Antiviral Oral Liquid Introduction
11.20.4 Allergan Revenue in Antiviral Oral Liquid Business (2016-2021)
11.20.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antiviral Oral Liquid Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Syrup
Table 3. Key Players of Oral suspension
Table 4. Key Players of Oral solution
Table 5. Key Players of Oral drop
Table 6. Key Players of Oral emulsion
Table 7. Key Players of Mixture
Table 8. Global Antiviral Oral Liquid Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Antiviral Oral Liquid Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Antiviral Oral Liquid Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Antiviral Oral Liquid Market Share by Regions (2016-2021)
Table 12. Global Antiviral Oral Liquid Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Antiviral Oral Liquid Market Share by Regions (2022-2027)
Table 14. Antiviral Oral Liquid Market Trends
Table 15. Antiviral Oral Liquid Market Drivers
Table 16. Antiviral Oral Liquid Market Challenges
Table 17. Antiviral Oral Liquid Market Restraints
Table 18. Global Antiviral Oral Liquid Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Antiviral Oral Liquid Market Share by Players (2016-2021)
Table 20. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Oral Liquid as of 2020)
Table 21. Ranking of Global Top Antiviral Oral Liquid Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Antiviral Oral Liquid Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antiviral Oral Liquid Product Solution and Service
Table 25. Date of Enter into Antiviral Oral Liquid Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiviral Oral Liquid Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Antiviral Oral Liquid Revenue Market Share by Type (2016-2021)
Table 29. Global Antiviral Oral Liquid Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Antiviral Oral Liquid Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Antiviral Oral Liquid Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Antiviral Oral Liquid Revenue Market Share by Application (2016-2021)
Table 33. Global Antiviral Oral Liquid Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Antiviral Oral Liquid Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Antiviral Oral Liquid Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Antiviral Oral Liquid Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Antiviral Oral Liquid Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Antiviral Oral Liquid Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Antiviral Oral Liquid Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Antiviral Oral Liquid Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Antiviral Oral Liquid Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Antiviral Oral Liquid Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Antiviral Oral Liquid Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Antiviral Oral Liquid Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Antiviral Oral Liquid Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Antiviral Oral Liquid Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Antiviral Oral Liquid Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Antiviral Oral Liquid Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Antiviral Oral Liquid Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Antiviral Oral Liquid Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Antiviral Oral Liquid Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Antiviral Oral Liquid Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Antiviral Oral Liquid Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Antiviral Oral Liquid Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Antiviral Oral Liquid Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Antiviral Oral Liquid Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Antiviral Oral Liquid Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Antiviral Oral Liquid Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Antiviral Oral Liquid Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Antiviral Oral Liquid Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Antiviral Oral Liquid Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Antiviral Oral Liquid Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Antiviral Oral Liquid Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Antiviral Oral Liquid Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Antiviral Oral Liquid Product
Table 68. Pfizer Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Antiviral Oral Liquid Product
Table 73. Roche Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Antiviral Oral Liquid Product
Table 78. Novartis Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Antiviral Oral Liquid Product
Table 83. Merck Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 84. Merck Recent Development
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Antiviral Oral Liquid Product
Table 88. GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 89. GlaxoSmithKline Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Antiviral Oral Liquid Product
Table 93. Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 94. Johnson & Johnson Recent Development
Table 95. AbbVie Company Details
Table 96. AbbVie Business Overview
Table 97. AbbVie Antiviral Oral Liquid Product
Table 98. AbbVie Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 99. AbbVie Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Antiviral Oral Liquid Product
Table 107. Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. AstraZeneca Company Details
Table 110. AstraZeneca Business Overview
Table 111. AstraZeneca Antiviral Oral Liquid Product
Table 112. AstraZeneca Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 113. AstraZeneca Recent Development
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Antiviral Oral Liquid Product
Table 117. Eli Lilly Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 118. Eli Lilly Recent Development
Table 119. Novo Nordisk Company Details
Table 120. Novo Nordisk Business Overview
Table 121. Novo Nordisk Antiviral Oral Liquid Product
Table 122. Novo Nordisk Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 123. Novo Nordisk Recent Development
Table 124. Amgen Company Details
Table 125. Amgen Business Overview
Table 126. Amgen Antiviral Oral Liquid Product
Table 127. Amgen Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 128. Amgen Recent Development
Table 129. Gilead Sciences Company Details
Table 130. Gilead Sciences Business Overview
Table 131. Gilead Sciences Antiviral Oral Liquid Product
Table 132. Gilead Sciences Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 133. Gilead Sciences Recent Development
Table 134. CSL Company Details
Table 135. CSL Business Overview
Table 136. CSL Antiviral Oral Liquid Product
Table 137. CSL Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 138. CSL Recent Development
Table 139. Takeda Pharmaceuticals Company Details
Table 140. Takeda Pharmaceuticals Business Overview
Table 141. Takeda Pharmaceuticals Antiviral Oral Liquid Product
Table 142. Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 143. Takeda Pharmaceuticals Recent Development
Table 144. Bayer Company Details
Table 145. Bayer Business Overview
Table 146. Bayer Antiviral Oral Liquid Product
Table 147. Bayer Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 148. Bayer Recent Development
Table 149. Celgene Company Details
Table 150. Celgene Business Overview
Table 151. Celgene Antiviral Oral Liquid Product
Table 152. Celgene Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 153. Celgene Recent Development
Table 154. Merck KGaA Company Details
Table 155. Merck KGaA Business Overview
Table 156. Merck KGaA Antiviral Oral Liquid Product
Table 157. Merck KGaA Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 158. Merck KGaA Recent Development
Table 159. Allergan Company Details
Table 160. Allergan Business Overview
Table 161. Allergan Antiviral Oral Liquid Product
Table 162. Allergan Revenue in Antiviral Oral Liquid Business (2016-2021) & (US$ Million)
Table 163. Allergan Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Oral Liquid Market Share by Type: 2020 VS 2027
Figure 2. Syrup Features
Figure 3. Oral suspension Features
Figure 4. Oral solution Features
Figure 5. Oral drop Features
Figure 6. Oral emulsion Features
Figure 7. Mixture Features
Figure 8. Global Antiviral Oral Liquid Market Share by Application: 2020 VS 2027
Figure 9. Adults Case Studies
Figure 10. Children Case Studies
Figure 11. Antiviral Oral Liquid Report Years Considered
Figure 12. Global Antiviral Oral Liquid Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Antiviral Oral Liquid Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Antiviral Oral Liquid Market Share by Regions: 2020 VS 2027
Figure 15. Global Antiviral Oral Liquid Market Share by Regions (2022-2027)
Figure 16. Global Antiviral Oral Liquid Market Share by Players in 2020
Figure 17. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Oral Liquid as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Antiviral Oral Liquid Revenue in 2020
Figure 19. Global Antiviral Oral Liquid Revenue Market Share by Type (2016-2021)
Figure 20. Global Antiviral Oral Liquid Revenue Market Share by Type (2022-2027)
Figure 21. North America Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Antiviral Oral Liquid Market Share by Type (2016-2027)
Figure 23. North America Antiviral Oral Liquid Market Share by Application (2016-2027)
Figure 24. North America Antiviral Oral Liquid Market Share by Country (2016-2027)
Figure 25. United States Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Antiviral Oral Liquid Market Share by Type (2016-2027)
Figure 29. Europe Antiviral Oral Liquid Market Share by Application (2016-2027)
Figure 30. Europe Antiviral Oral Liquid Market Share by Country (2016-2027)
Figure 31. Germany Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Antiviral Oral Liquid Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Antiviral Oral Liquid Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Antiviral Oral Liquid Market Share by Region (2016-2027)
Figure 41. China Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Antiviral Oral Liquid Market Share by Type (2016-2027)
Figure 49. Latin America Antiviral Oral Liquid Market Share by Application (2016-2027)
Figure 50. Latin America Antiviral Oral Liquid Market Share by Country (2016-2027)
Figure 51. Mexico Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Antiviral Oral Liquid Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Antiviral Oral Liquid Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Antiviral Oral Liquid Market Share by Country (2016-2027)
Figure 57. Turkey Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Antiviral Oral Liquid Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 71. Novo Nordisk Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 72. Amgen Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 73. Gilead Sciences Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 74. CSL Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 75. Takeda Pharmaceuticals Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 76. Bayer Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 77. Celgene Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 78. Merck KGaA Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 79. Allergan Revenue Growth Rate in Antiviral Oral Liquid Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

以下、関連資料のご紹介

世界の抗ウイルス療法市場規模・現状・予測（2021年-2027年）

Global Antiviral Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3845 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、抗ウイルス療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘルペス抗ウイルス薬、肝炎抗ウイルス薬、HIV抗ウイルス薬、インフルエンザ抗ウイルス薬、その他）、用途別市場規模（病院、診療所、外来手術セ...

世界の呼吸器抗ウイルス治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Antiviral Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4815 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、呼吸器抗ウイルス治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インフルエンザ、細気管支炎、肺炎、上気道感染症（URTI）、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域...

世界の抗ウイルス併用療法市場規模・現状・予測（2021年-2027年）

Global Antiviral Combination Therapies Market Size, Status and Forecast 2021-2027
QFJ1-3843 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、抗ウイルス併用療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NRTI / NNRTI、インテグラーゼ阻害剤/ NRTI、NRTI /プロテアーゼ阻害剤、その他）、用途別市場規模（HIV、肝炎、そ...

世界の新規抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Novel Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4596 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、新規抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター、その他）、用途別市場規模（肝炎治療、HIV/AIDS治療、ヘルペ...

世界の肝抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Hepatic Antiviral Drug Market Size, Status and Forecast 2021-2027
QFJ1-4301 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、肝抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院、ホームケア、診療所、その他）、主要地域別...

世界のインフルエンザ用抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Influenza Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4366 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、インフルエンザ用抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、アダマンタン、その他）、用途別市場規模（病院、クリニック、外科医院、薬局、その他）、...

世界の直接作用型抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4139 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、直接作用型抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NS3 / 4Aプロテアーゼ阻害剤、ヌクレオシド＆ヌクレオチドNS5Bポリメラーゼ阻害剤、NS5A阻害剤、非ヌクレオシドNS5Bポ...

世界のインフルエンザ (Flu) 抗ウイルス薬市場規模・現状・予測（2021年-2027年）

Global Influenza (Flu) Antiviral Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5801 2021年6月 121Pages
QYResearch社発行の本調査レポートでは、インフルエンザ (Flu) 抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（浸透＆剥離阻害剤、DNAポリメラーゼ阻害剤、逆転写酵素阻害剤、タンパク質阻害剤、ノイラミニダーゼ阻害剤、広域スペ...

世界の抗ウイルスコーティング剤市場規模・現状・予測（2021年-2027年）

Global Antiviral Coatings Market Size, Status and Forecast 2021-2027
QFJ1-5407 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗ウイルスコーティング剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（水系コーティング剤、溶剤系コーティング剤、その他）、用途別市場規模（建設、自動車、消費財、繊維、その他）、主要地域別市場規模（北...

世界の抗ウイルス漢方薬市場規模・現状・予測（2021年-2027年）

Global Antiviral Traditional Chinese Medicine Market Size, Status and Forecast 2021-2027
QFJ1-5592 2021年6月 126Pages
QYResearch社発行の本調査レポートでは、抗ウイルス漢方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗HIV、抗CVB、抗HBV、抗インフルエンザウイルス、抗ヘルペスウイルス、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規...

流動パラフィン経口エマルジョンのグローバル市場調査 2019年 The global Liquid Paraffin Oral Emulsion market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Liquid Paraffin Oral Emulsion volume and value at global level, regional level and company level. From a glob…
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
世界の経口高分子製剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Macromolecule Formulation Market The global Oral Macromolecule Formulation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の口腔ケア＆口腔衛生市場規模・現状・予測（2021年-2027年） The increase in the prevalence of dental caries, periodontal diseases, and other dental diseases; growing awareness about oral hygiene; rising dental healthcare expenditure; and increasing number of small/private clinics with dental dispensaries are some of the factors contributing to the growth of …
世界の経口免疫賦活剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Immunostimulant Market The global Oral Immunostimulant market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…